Treatment of paediatric visceral leishmaniasis: amphotericin B or pentavalent antimony compounds?

Kafetzis, D A

Treatment of paediatric visceral leishmaniasis: amphotericin B or pentavalent antimony compounds? [electronic resource] - International journal of antimicrobial agents Jan 2005 - 26-30 p. digital

Publication Type: Journal Article

0924-8579

10.1016/j.ijantimicag.2004.09.011 doi


Adolescent
Amphotericin B--therapeutic use
Animals
Antimony
Antiprotozoal Agents--therapeutic use
Child
Child, Preschool
Female
Greece
Humans
Infant
Infant, Newborn
Leishmania infantum--drug effects
Leishmaniasis, Visceral--drug therapy
Liposomes
Male
Meglumine--therapeutic use
Meglumine Antimoniate
Organometallic Compounds--therapeutic use
Treatment Outcome